Annual Accounts Receivable
$231.30 K
+$185.30 K+402.83%
December 1, 2023
Summary
- As of February 8, 2025, SXTP annual accounts receivable is $231.30 thousand, with the most recent change of +$185.30 thousand (+402.83%) on December 1, 2023.
- During the last 3 years, SXTP annual accounts receivable has fallen by -$628.10 thousand (-73.09%).
- SXTP annual accounts receivable is now -73.09% below its all-time high of $859.40 thousand, reached on December 1, 2020.
Performance
SXTP Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$323.80 K
+$27.40 K+9.24%
September 1, 2024
Summary
- As of February 8, 2025, SXTP quarterly accounts receivable is $323.80 thousand, with the most recent change of +$27.40 thousand (+9.24%) on September 1, 2024.
- Over the past year, SXTP quarterly accounts receivable has increased by +$7600.00 (+2.40%).
- SXTP quarterly accounts receivable is now at all-time high.
Performance
SXTP Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SXTP Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +402.8% | +2.4% |
3 y3 years | -73.1% | +2.4% |
5 y5 years | -73.1% | +2.4% |
SXTP Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +402.8% | at high | +603.9% |
5 y | 5-year | -73.1% | +402.8% | at high | +603.9% |
alltime | all time | -73.1% | +402.8% | at high | +603.9% |
60 Degrees Pharmaceuticals Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $323.80 K(+9.2%) |
Jun 2024 | - | $296.40 K(-6.3%) |
Mar 2024 | - | $316.20 K(+36.7%) |
Dec 2023 | $231.30 K | $231.30 K(+67.6%) |
Sep 2023 | - | $138.00 K(+10.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $125.50 K(+51.4%) |
Mar 2023 | - | $82.90 K(+80.2%) |
Dec 2022 | $46.00 K(-68.6%) | $46.00 K(-76.4%) |
Sep 2022 | - | $195.00 K(+33.2%) |
Dec 2021 | $146.40 K(-83.0%) | $146.40 K |
Dec 2020 | $859.40 K | - |
FAQ
- What is 60 Degrees Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals annual accounts receivable year-on-year change?
- What is 60 Degrees Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals quarterly accounts receivable year-on-year change?
What is 60 Degrees Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of SXTP is $231.30 K
What is the all time high annual accounts receivable for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high annual accounts receivable is $859.40 K
What is 60 Degrees Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, SXTP annual accounts receivable has changed by +$185.30 K (+402.83%)
What is 60 Degrees Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of SXTP is $323.80 K
What is the all time high quarterly accounts receivable for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high quarterly accounts receivable is $323.80 K
What is 60 Degrees Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, SXTP quarterly accounts receivable has changed by +$7600.00 (+2.40%)